Milestone Pharmaceuticals Inc. Share Price
NASDAQ: MIST | Micro CapMilestone Pharmaceuticals Inc. Stock Performance
Open $1.18 | Prev. Close $1.19 | Circuit Range N/A |
Day Range $1.14 - $1.18 | Year Range $1.00 - $3.05 | Volume 30,988 |
Average Traded $1.15 |
Milestone Pharmaceuticals Inc. Share Price Today
As of 29 August 2026, Milestone Pharmaceuticals Inc.'s share price is $1.16. The stock opened at $1.18, compared to its previous close of $1.19. During today's trading session, Milestone Pharmaceuticals Inc.'s share price traded between $1.14 and $1.18, with an average price of $1.16. Over the past 52 weeks, the stock has recorded a high of $3.05 and a low of $1.00. In terms of performance, Milestone Pharmaceuticals Inc.'s share price has declined by 32.36% over the last six months and is down 36.61% on a year-on-year basis.
Milestone Pharmaceuticals Inc. Share Price Chart
Milestone Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Market Cap $97.53M | PE Ratio (TTM) -1.55 | Dividend Yield N/A |
EPS (TTM) $-0.75 | Revenue (TTM) $1.55M | Return On Equity (TTM) -150.97% |
Profit Margin -4078.78% | Debt to Equity 1.72 | Quarterly Earnings Growth YoY -26.31% |
Milestone Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
Milestone Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Milestone Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.08 | $1.19 | +7.69% |
Jul 2026 | $1.35 | $1.10 | -17.54% |
Jun 2026 | $1.39 | $1.34 | -5.96% |
May 2026 | $1.79 | $1.43 | -20.83% |
Apr 2026 | $1.24 | $1.80 | +50.00% |
Mar 2026 | $1.69 | $1.20 | -30.03% |
Feb 2026 | $1.93 | $1.72 | -10.68% |
Jan 2026 | $2.05 | $1.92 | -5.19% |
Dec 2025 | $2.68 | $2.02 | -24.30% |
Nov 2025 | $1.95 | $2.67 | +38.96% |
Oct 2025 | $2.00 | $1.93 | -4.18% |
Sep 2025 | $1.87 | $2.01 | +9.78% |